Introduction Interstitial lung fibrosis is a chronic, progressive, and irreversible lung disease characterized by interstitial inflammation and excessive collagen deposition. It is known as the
Introduction As the “core organ” of human metabolism, the liver’s lipid metabolism status directly reflects the body’s health level, and TC (total cholesterol) and TG
Introduction Osteoarthritis (OA) is a common degenerative joint disease, especially the most common knee osteoarthritis, which is mainly driven by “degeneration”. The main manifestations include
🎉Event: BIO-EUROPE SPRING 2026 📅Date: 23–25 March 2026 📍 Venue: Feira Internacional de Lisboa, Pavilion 2, Lisbon, Portugal 💁 KCI‘s Booth: #34 About KCI KCI Biotech and its wholly-owned subsidiaries
On October 28, 2024, Ms. Li, the R&D director of Chunhai Biotechnology, came to KCI BioTech and presented us with a bright banner. On
Recently, KAL Biotech Inc. (hereinafter referred to as “KAL Biotech”), a wholly-owned subsidiary of KCI Biotech Inc, successfully obtained the “Experimental Animal Production License” officially issued
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
